Chugai"s Hemlibra Gains Positive CHMP Opinion in Severe Hemophilia A Without Inhibitors
TOKYO--(BUSINESS WIRE)--Feb 3, 2019--Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that Roche has received notification that the EU Committee for Medicinal Products…
